{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:47:52Z","timestamp":1780105672546,"version":"3.54.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371401"],"award-info":[{"award-number":["81371401"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501112"],"award-info":[{"award-number":["81501112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Planning Project of Guangdong","award":["2013B021800199"],"award-info":[{"award-number":["2013B021800199"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong","doi-asserted-by":"publisher","award":["S2012010009715"],"award-info":[{"award-number":["S2012010009715"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong","doi-asserted-by":"publisher","award":["S2013010014033"],"award-info":[{"award-number":["S2013010014033"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong","doi-asserted-by":"publisher","award":["2016A030310327"],"award-info":[{"award-number":["2016A030310327"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Program of Guangzhou","award":["2014J4100083"],"award-info":[{"award-number":["2014J4100083"]}]},{"name":"Science and Technology Program of Guangzhou","award":["2013J4100068"],"award-info":[{"award-number":["2013J4100068"]}]},{"name":"Medical Scientific Research Foundation of Guangdong Province","award":["A2014015"],"award-info":[{"award-number":["A2014015"]}]},{"name":"Science and Technology Program of Foshan","award":["2015AB00295"],"award-info":[{"award-number":["2015AB00295"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.parkreldis.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T17:37:36Z","timestamp":1538761056000},"page":"46-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Is hyperhomocysteinemia associated with the structural changes of the substantia nigra in Parkinson's disease? A two-year follow-up study"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7792-7208","authenticated-orcid":false,"given":"Guohua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1727-2670","authenticated-orcid":false,"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3492-4669","authenticated-orcid":false,"given":"Yuhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2018.10.008_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.parkreldis.2008.02.007","article-title":"Vascular pathology in patients with idiopathic Parkinson's disease","volume":"15","author":"Rektor","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2018.10.008_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbi.2012.11.017","article-title":"Loss of substance P and inflammation precede delayed neurodegeneration in the substantia nigra after cerebral ischemia","volume":"29","author":"Rodriguez-Grande","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.parkreldis.2018.10.008_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.parkreldis.2017.06.020","article-title":"The effects of striatal silent lacunar infarction on the substantia nigra and movement disorders in Parkinson's disease: a follow-up study","volume":"43","author":"Zhang","year":"2017","journal-title":"Park. Relat. Disord."},{"issue":"7374","key":"10.1016\/j.parkreldis.2018.10.008_bib4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.parkreldis.2018.10.008_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jcp.21757","article-title":"Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway","volume":"220","author":"Tyagi","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.parkreldis.2018.10.008_bib6","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1089\/ars.2007.1750","article-title":"Vascular oxidant stress and inflammation in hyperhomocysteinemia","volume":"9","author":"Papatheodorou","year":"2007","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.parkreldis.2018.10.008_bib7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/mrm.20508","article-title":"Diffusional kurtosis imaging: the quantification of non-Gaussian water diffusion by means of magnetic resonance imaging","volume":"53","author":"Jensen","year":"2005","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.parkreldis.2018.10.008_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/207624","article-title":"Diffusion kurtosis imaging of substantia nigra is a sensitive method for early diagnosis and disease evaluation in Parkinson's disease","author":"Zhang","year":"2015","journal-title":"Parkinson's Dis."},{"issue":"5","key":"10.1016\/j.parkreldis.2018.10.008_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2018.10.008_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mds.870090112","article-title":"Unified Parkinson's disease rating scale characteristics and structure: the Cooperative Multicentric Group","volume":"9","author":"Mart\u00ednez-Mart\u00edn","year":"1994","journal-title":"Mov. Disord."},{"issue":"16","key":"10.1016\/j.parkreldis.2018.10.008_bib11","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1212\/01.wnl.0000340982.01727.6e","article-title":"High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease","volume":"72","author":"Vaillancourt","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2018.10.008_bib12","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and Neurodegeneration","volume":"12","author":"M Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2018.10.008_bib13","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa022066","article-title":"Silent brain infarcts and the risk of dementia and cognitive decline","volume":"348","author":"Vermeer","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2018.10.008_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.archger.2008.09.005","article-title":"The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson's disease","volume":"49","author":"Lee","year":"2009","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.parkreldis.2018.10.008_bib15","first-page":"276","article-title":"The influence of vascular risk factors and white matter hyperintensities on the degree of motor impairment in Parkinson's disease","volume":"40","author":"Derejko","year":"2006","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.parkreldis.2018.10.008_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jocn.2016.03.032","article-title":"Striatal silent lacunar infarction is associated with changes to the substantia nigra in patients with early-stage Parkinson's disease: a diffusion kurtosis imaging study","volume":"33","author":"Zhang","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.parkreldis.2018.10.008_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1515\/CCLM.2011.084","article-title":"Homocysteine: a biomarker in neurodegenerative diseases","volume":"49","author":"Herrmann","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2018.10.008_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.mcn.2004.09.007","article-title":"S-adenosylmethionine\/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production","volume":"28","author":"Fuso","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.parkreldis.2018.10.008_bib19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archneur.59.6.972","article-title":"Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease","volume":"59","author":"Pratic\u00f2","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2018.10.008_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3988\/jcn.2014.10.4.281","article-title":"Hyperhomocysteinemia and neurologic disorders: a review","volume":"10","author":"Ansari","year":"2014","journal-title":"J. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2018.10.008_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/nu7010074","article-title":"Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis","volume":"7","author":"Yang","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.parkreldis.2018.10.008_bib22","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1161\/01.CIR.94.10.2410","article-title":"Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians","volume":"94","author":"Ma","year":"1996","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.parkreldis.2018.10.008_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0304-3940(01)01972-3","article-title":"Decrease ofmethionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's Disease","volume":"308","author":"M\u00fcller","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.parkreldis.2018.10.008_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s007020200013","article-title":"3-OMD and homocysteine plasma levels in parkinsonian patients","volume":"109","author":"M\u00fcller","year":"2002","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.parkreldis.2018.10.008_bib25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.parkreldis.2013.04.006","article-title":"The effects of silent cerebral ischemic lesions on the prognosis of idiopathic Parkinson's disease","volume":"19","author":"Song","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2018.10.008_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1589747","article-title":"The effect of hyperhomocysteinemia on motor symptoms, cognitive status, and vascular risk in patients with Parkinson's disease","author":"Kocer","year":"2016","journal-title":"Parkinson's Dis."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380201830436X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380201830436X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T17:34:50Z","timestamp":1693935290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380201830436X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":26,"alternative-id":["S135380201830436X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.10.008","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is hyperhomocysteinemia associated with the structural changes of the substantia nigra in Parkinson's disease? A two-year follow-up study","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}